President, CEO and director John Miller Intends to Purchase 500,000 Shares in THC BioMed Intl Ltd.

VANCOUVER, May 22, 2019 /PRNewswire/ – THC BioMed Intl Ltd. (THC.CN), (“THC” or the “Company”) announces that John Miller, President, Chief Executive Officer and director of the Company, plans to purchase up to 500,000 additional common shares (the “Shares”) in the capital of the Company. Mr. Miller is purchasing the Shares for investment purposes, and commented, “I am very satisfied with the progress THC BioMed has made to become a profitable company.” He currently holds 25,318,071 of the 146,379,363 issued and outstanding common shares in the capital of the Company representing 17.3%. THC is on the leading edge of scientific research and the development of products and services related to the medical cannabis industry.